|Product Type||Finished Product|
|Grade Standard||Medicine Grade|
Perinorm (2 ml) is a gastrointestinal stimulant and antinauseant, prescribed for heartburn and esophagitis due to GERD and for treating patients who have gastroparesis (partial paralysis of the stomach) and prevention of nausea and vomiting associated with cancer chemotherapy.
Warnings and Precautions:
Caution needed for children, elderly, patients with history of liver or kidney disease, porphyria (group of inherited or acquired disorders of certain enzymes), epilepsy, Parkinson''''s disease, diabetes, history of depression.
It may cause dizziness. Do not drive a car or operate machinery until you know how this medication affects you.
Do not drink alcohol or use medicines that may cause drowsiness.
Do not take more than the recommended dose or use this medication for longer than 12 weeks without checking with your doctor.
Heart: Acute heart failure, slow heart rate, fluid retention, high blood pressure, low blood pressure and fast heart rate.
Central Nervous System: Sedation, dizziness, restlessness, involuntary body movements, spasms, depression, malignant neuroleptic syndrome (condition where patient experiences rigidity, decreased consciousness, fever and fluctuating blood pressure and heart rate – may be fatal).
Gastrointestinal: Bowel disturbances, primarily diarrhea and nausea.
Skin: Transient flushing of face or upper body with high IV doses.
Hormone: Galactorrhea ( spontaneous flow of milk from the breast), breast enlargement in men and increase in serum prolactin.
Genitourinary: Absence of a menstrual period, elevation of aldosterone, fluid retention, impotence, incontinence and urinary frequency.
Liver: Liver toxicity (rare).
|Packaging Size||10 Ml|
We are one of the leading retailer and suppliers of BAYROCIN 1 SHOT 30ML.
Enrofloxacin is a broad spectrum antibiotic used in veterinary medicine to treat animals afflicted with certain bacterial infections. This drug belongs to a class of antibiotics known as fluoroquinolones and is not effective against infections caused by viruses, fungi or parasites.
Imicarb® Injection manufacturer is SavaVet. Imicarb® Injection comprises the active ingredient called Imidocarb – a carbanilide derivative with antiprotozoal activity.
treatment and prevention of canine babesiosis (a malaria-like parasitic disease caused by infection with Babesia);
treatment of canine ehrlichiosis (tick-borne disease caused by infection with bacteria of the genus Ehrlichia).
Tick-borne diseases have a tendency to cause cross-infection and Imicarb® may be capable of fighting both canine ehrlichiosis and babesiosis simultaneously.
MOA (mechanism of action):
Imidocarb appears to act directly on the parasite, causing the alteration in number and size of nuclei and in morphology (vacuolation) of the cytoplasm. The antiprotozoal activity is derived from the carbanilide acting on glycolysis of the parasite.
Imicarb® is suitable for intramuscular (IM) or subcutaneous injection.
Intramuscular or subcutaneous: 0,5-1,0 ml per 10 kg of body weight.
Imicarb® is usually given in the form of two injections, two weeks apart.
This drug should not be given intravenously (IV), and it should be noted that it can cause burns to the skin.
Keep the injection site and needle free from the residue of Imicarb®.
Imicarb® injection can be given instead of tetracycline or in conjunction with Doxycycline.
Imicarb® should only be given as a secondary alternative to Tetracycline or Doxycycline.